<DOC>
	<DOCNO>NCT00404053</DOCNO>
	<brief_summary>In view safety profile result clinical trial , clopidogrel become standard treatment patient acute coronary syndrome ( ACS ) drug elute stent ( DES ) implantation . Two large study patient ACS show pretreatment clopidogrel beneficial effect . The pretreatment regimens give mean 6 day intervention observational PCI-CURE trial 3 24 h randomize CREDO trial respectively . Accordingly , current clinical practice carry pretreatment 300mg load dose clopidogrel least 6 h DES implantation procedure patient ACS . Compared 300mg clopidogrel load dose , 600mg load dose exhibit superior antiplatelet effect improve short-term clinical outcome patient undergo DES implantation ACS accord recent publication . But despite clopidogrel 600mg load dose routine use 75mg per day maintain dose , recurrent ischemic event occur patient . Therefore , goal study evaluate efficacy 600mg load dose clopidogrel plus 150mg per day maintain dose patient ACS undergoing DES implantation . ACS patient undergo DES implantation receive plan 600mg load dose clopidogrel pretreatment eligible study . All enrol patient randomized receive daily clopidogrel 75 mg 150mg maintaining dos start soon post-PCI , addition daily aspirin 100 mg , last first month DES implantation . One month later , patient receive daily clopidogrel 75mg 9~12month DES implantation . The primary endpoint include death cause , myocardial infarction , revascularization target lesson , sub-acute late stent thrombosis one year PCI , The secondary endpoint major minor bleed event . The study power test hypothesis high maintain dose ( 150mg ) clopidogrel reduce major adverse cardiac event compare currently use common dose ( 75 mg ) one year follow PCI .</brief_summary>
	<brief_title>Clopidogrel Maintaining Dosage Acute Coronary Syndrome After Drug Eluting Stent Implantation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Diagnosed ACS plan pretreatment 600mg load dose commercially available clopidogrel ( Plavix ) . age 18 Years Presence one several stenosis native coronary artery require PCI suitable DES implantation . Willing able sign inform consent . A history bleed diathesis . New York Heart Association functional class IV . Prior PCI coronary bypass graft &lt; 3 month . contraindication clopidogrel aspirin ( White blood cell count &lt; 4×109/L platelet count &lt; 100 g.l1 ; creatinine clearance &lt; 25 ml • min1 ; active liver disease ) . use glycoprotein IIb/IIIa inhibitor PCI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>